These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 27993355

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.
    Boige V, Malka D, Elias D, Castaing M, De Baere T, Goere D, Dromain C, Pocard M, Ducreux M.
    Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hepatic arterial infusion chemotherapy prior to standard systemic chemotherapy in patients with highly advanced unresectable liver metastases from colorectal cancer: a report of three patients.
    Iguchi T, Idani H, Asami S, Endo H, Inaba Y, Arai Y, Kanazawa S.
    Acta Med Okayama; 2011 Feb; 65(1):49-53. PubMed ID: 21339796
    [Abstract] [Full Text] [Related]

  • 6. Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis.
    Martin RC, Scoggins CR, Schreeder M, Rilling WS, Laing CJ, Tatum CM, Kelly LR, Garcia-Monaco RD, Sharma VR, Crocenzi TS, Strasberg SM.
    Cancer; 2015 Oct 15; 121(20):3649-58. PubMed ID: 26149602
    [Abstract] [Full Text] [Related]

  • 7. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.
    Kemeny N, Jarnagin W, Paty P, Gönen M, Schwartz L, Morse M, Leonard G, D'Angelica M, DeMatteo R, Blumgart L, Fong Y.
    J Clin Oncol; 2005 Aug 01; 23(22):4888-96. PubMed ID: 16009951
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic review.
    Richardson AJ, Laurence JM, Lam VW.
    J Vasc Interv Radiol; 2013 Aug 01; 24(8):1209-17. PubMed ID: 23885916
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Complete pathological response of unresectable liver metastases from colorectal cancer after trans-arterial chemoembolization with drug-eluting beads loaded with irinotecan (DEBIRI) and concomitant systemic FOLFOX: A case report from the FFCD 1201 trial.
    Pernot S, Artru P, Mithieux F, Marsot J, Watkin E, Pellerin O, Lledo G, Chalabreysse P, Desramé J, Taieb J.
    Clin Res Hepatol Gastroenterol; 2015 Dec 01; 39(6):e73-7. PubMed ID: 26141343
    [Abstract] [Full Text] [Related]

  • 13. Fluorouracil, leucovorin and irinotecan combined with intra-arterial hepatic infusion of drug-eluting beads preloaded with irinotecan in unresectable colorectal liver metastases: side effects and results of a concomitant treatment schedule. Clinical investigation.
    Kekez D, Badzek S, Prejac J, Gorsic I, Golem H, Librenjak N, Perkov D, Smiljanic R, Plestina S.
    Tumori; 2014 Dec 01; 100(5):499-503. PubMed ID: 25343542
    [Abstract] [Full Text] [Related]

  • 14. Hepatic Arterial Infusion Chemotherapy for Unresectable Liver Metastases of Colorectal Cancer: A Multicenter Retrospective Study.
    Lim A, Le Sourd S, Senellart H, Luet D, Douane F, Perret C, Bouvier A, Métairie S, Cauchin E, Rougier P, Matysiak-Budnik T, Touchefeu Y.
    Clin Colorectal Cancer; 2017 Dec 01; 16(4):308-315. PubMed ID: 28433600
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hepatic Arterial Infusion Chemotherapy of 5-Fluorouracil for Patients with Unresectable Liver Metastases from Colorectal Cancer Refractory to Standard Systemic Chemotherapy: A Multicenter Retrospective Study.
    Sato Y, Inaba Y, Aramaki T, Sone M, Morita Y, Nishiofuku H, Tanaka T, Miyazaki M, Matsueda K, Arai Y.
    Oncology; 2020 Dec 01; 98(5):267-272. PubMed ID: 32092755
    [Abstract] [Full Text] [Related]

  • 18. Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.
    Pak LM, Kemeny NE, Capanu M, Chou JF, Boucher T, Cercek A, Balachandran VP, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, D'Angelica MI.
    J Surg Oncol; 2018 Mar 01; 117(4):634-643. PubMed ID: 29165816
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases.
    Bhutiani N, Akinwande O, Martin RC.
    World J Surg; 2016 May 01; 40(5):1178-90. PubMed ID: 26711640
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.